---
title: "12 Health Care Stocks Moving In Wednesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293503009.md"
description: "During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Advanced Biomed (+108.6%), Lakewood-Amedex (+82.79%), and Rani Therapeutics (+25.87%). Conversely, major losers featured China Pharma Holding (-77.3%) and Zhengye Biotechnology (-49.3%). Other notable decliners were Picard Medical, Axe Compute, QTREX Quantum, and Catheter Precision."
datetime: "2026-07-22T17:05:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293503009.md)
  - [en](https://longbridge.com/en/news/293503009.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293503009.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Wednesday's Intraday Session

### Gainers

-   **Advanced Biomed** (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday's regular session. The company's market cap stands at $11.5 million.
-   **Lakewood-Amedex** (NASDAQ:LABT) shares moved upwards by 82.79% to $3.4. The market value of their outstanding shares is at $3.2 million.
-   **Rani Therapeutics Hldgs** (NASDAQ:RANI) shares increased by 25.87% to $0.87. The company's market cap stands at $77.6 million.
-   **Arrowhead Pharma** (NASDAQ:ARWR) shares rose 21.39% to $90.46. The company's market cap stands at $10.4 billion.
-   **InMed Pharmaceuticals** (NASDAQ:INM) stock moved upwards by 13.63% to $1.75. The company's market cap stands at $8.2 million.
-   **Processa Pharma** (NASDAQ:PCSA) shares moved upwards by 11.61% to $2.5. The company's market cap stands at $6.2 million.

### Losers

-   **China Pharma Holding** (AMEX:CPHI) shares fell 77.3% to $1.84 during Wednesday's regular session. The market value of their outstanding shares is at $328.2 million.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) stock declined by 49.3% to $1.45. The market value of their outstanding shares is at $135.0 million.
-   **Picard Medical** (AMEX:PMI) stock decreased by 27.07% to $0.09. The company's market cap stands at $12.3 million.
-   **Axe Compute** (NASDAQ:AGPU) shares fell 26.73% to $6.99. The market value of their outstanding shares is at $108.6 million.
-   **QTREX Quantum** (NASDAQ:QTEX) shares decreased by 24.74% to $0.89. The market value of their outstanding shares is at $65.7 million.
-   **Catheter Precision** (AMEX:VTAK) stock decreased by 23.07% to $0.38. The company's market cap stands at $1.7 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)
- [QTEX.US](https://longbridge.com/en/quote/QTEX.US.md)
- [AGPU.US](https://longbridge.com/en/quote/AGPU.US.md)
- [RANI.US](https://longbridge.com/en/quote/RANI.US.md)
- [VTAK.US](https://longbridge.com/en/quote/VTAK.US.md)
- [ADVB.US](https://longbridge.com/en/quote/ADVB.US.md)
- [LABT.US](https://longbridge.com/en/quote/LABT.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [ARWR.US](https://longbridge.com/en/quote/ARWR.US.md)
- [INM.US](https://longbridge.com/en/quote/INM.US.md)
- [PCSA.US](https://longbridge.com/en/quote/PCSA.US.md)

## Related News & Research

- [Lakewood-Amedex Biotherapeutics Becomes a B2i Digital Featured Company](https://longbridge.com/en/news/296957982.md)
- [Catheter Precision announces annual shareholder meeting webcast](https://longbridge.com/en/news/296649623.md)
- [QTREX Quantum Secures $10 Million Registered Direct Equity Financing](https://longbridge.com/en/news/296540188.md)
- [Flyte WebApp tops 10,000 consumer accounts as growth accelerates](https://longbridge.com/en/news/296483061.md)
- [Catheter Precision receives first LockeT purchase order via Cardinal Health distribution channel](https://longbridge.com/en/news/297182206.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**